No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Outlook Therapeutics, Maintains $30 Price Target
Buy Rating Affirmed for Outlook Therapeutics on Strong EU Prospects and Solid Financial Position
Q2 2024 Outlook Therapeutics Inc Earnings Call
Earnings Call Summary | Outlook Therapeutics(OTLK.US) Q2 2024 Earnings Conference
The following is a summary of the Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript:Financial Performance:Outlook Therapeutics recently secured funding through a private placement, ge
Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
Express News | Outlook Therapeutics Inc - Qtrly Shr Loss $8.01